Article History
Received: 1 July 2021
Revised: 20 August 2021
Accepted: 6 September 2021
First Online: 8 October 2021
Declarations
:
: Not applicable.
: Not applicable.
: Consent to publish has been obtained from all authors.
: O. Sahin is co-founder of OncoCube Therapeutics LLC; founder and president of LoxiGen, Inc.; and is also a recipient of a research grant from Halozyme Therapeutics, Inc. The other authors declare that they have no conflict of interest.